CompletedNot Applicable

LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in Jordan

Jordan140 participantsStarted 2024-01-02

Plain-language summary

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder impacting women of reproductive age. Characterized by chronic anovulation, hyperandrogenism, and the presence of multiple small ovarian cysts. Despite its widespread occurrence, a comprehensive study particularly within the Jordanian population remains limited. Aim of the study: The study aimed to assess the serum levels of the Luteinizing hormone (LH), Follicle stimulating hormone (FSH), LH/FSH ratio, Testosterone, Prolactin, and Ferritin in Jordanian women diagnosed with PCOS

Who can participate

Age range20 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 20-45 PCOS diagnosed females Jordanian Exclusion Criteria: * younger than 20 older than 45 Non -Jordanian

What they're measuring

Hormonal level

Timeframe: 3 months

Biochemical marker

Timeframe: 3 months

Trial details

NCT IDNCT07112768

SponsorFuture University in Egypt

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-04-10

View on ClinicalTrials.gov More PCOS (Polycystic Ovary Syndrome) trials